NOX a 25 million market cap and 2 million in funding for encouraging pancreatic pre clinical results
NYR 10 million in funding and 10 million market cap for excellent preclinical results when peers after pre clinical success where trading at a 70-100 million market cap
Funny, let the next 1-3 months come into play as GLP, phase 1 and Walter Reed come to a conclusion and we apply for phase 2 through FDA and officialise the partnership with US department of defence.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-142
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
